A Retrospective Study of the Novel Combination of Paclitaxel and S1 for Pretreated Advanced Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 1421-9794|58|6|454-460

ISSN： 0009-3157

Source： Chemotherapy, Vol.58, Iss.6, 2013-01, pp. : 454-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 61, Iss. 2, 2015-0 ,pp. : 93-98

Karger

Access to resources Recommend Favorite

Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells

By Klimaszewska-Wiśniewska Anna   Hałas-Wiśniewska Marta   Grzanka Alina   Grzanka Dariusz  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-02 ,pp. : 661-661

MDPI

Access to resources Recommend Favorite

Feasibility Study of Adjuvant Chemotherapy of S-1 and Carboplatin for Completely Resected Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-06 ,pp. : 35-41

Karger

Access to resources Recommend Favorite

Gemcitabine Plus Vinorelbine as the Second-Line Treatment and Beyond in Elderly Patients with Platinum-Pretreated Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 60, Iss. 4, 2015-04 ,pp. : 267-273

Karger

Access to resources Recommend Favorite

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 78-83

Karger

Access to resources Recommend Favorite